Items Tagged ‘breast cancer’

August 17, 2020

Mayo Clinic and Middlesex Health partner to transform genetic cancer research

By Susan Murphy Susan Murphy

By Alyson Gonzalez What began as an inquiry sparked during a research brainstorming session, evolved into meaningful collaboration for a community cancer center in Connecticut. Through the Mayo Clinic Care Network relationship, Middlesex Health and Mayo Clinic are working together to improve the lives of cancer patients and their families through impactful research. Approximately one […]

View full entry

Tags: breast cancer


August 12, 2020

Could population genetic screening improve public health?

By Colette Gallagher Colette Gallagher

Hereditary BRCA-related breast and ovarian cancer, Lynch syndrome and familial hypercholesterolemia are estimated to be relatively prevalent in the general population but poorly found using traditional risk screening. In a typical medical practice, genetic testing for these conditions is based on personal or family history, ethnic background or other demographic characteristics, that may not always […]

View full entry

Tags: #Familial hypercholesterolemia, breast cancer, Dr. Matthew Ferber, lynch syndrome, mayo clinic, Mayo Clinic Center for Individualized Medicine, ovarian cancer, population health genomics, Research


September 25, 2019

The BEAUTY of it: award recognizes personalized medicine approach for breast cancer

By Barbara J. Toman Barbara J. Toman

A Mayo Clinic research team supported by the Center for Individualized Medicine is making significant breakthroughs — and gaining recognition for them. The Breast Cancer Genome-Guided Therapy (BEAUTY) project has received the 2019 Mayo Clinic Team Science Award, given for interdisciplinary work that substantially advances Mayo’s research. The award cites BEAUTY’s discoveries about breast tumor […]

View full entry

Tags: #targeted therapies, BEAUTY trial, breast cancer, center for individualized medicine, chemotherapy, chemotherapy-resistant breast cancer, Dr. Judy Boughey, Dr. Liewei Wang, Dr. Matthew Goetz, Genetics, genomics, individualized medicine


August 29, 2019

Gerstner awards boost research into rheumatoid arthritis, breast cancer

By Barbara J. Toman Barbara J. Toman

Creating tools to identify optimal treatments for rheumatoid arthritis and breast cancer are focuses of the 2019 Gerstner Family Career Development Awards. This year’s awardees are Elena Myasoedova, M.D., Ph.D., a rheumatologist at Mayo Clinic’s Minnesota campus and Bhavika Patel, M.D., a radiologist at Mayo’s Arizona campus. Both researchers seek to apply data centric approaches […]

View full entry

Tags: #Artificial Intelligence, #personalized therapies, biomarkers, breast cancer, center for individualized medicine, circulating tumor DNA, Dr. Bhavika Patel, Dr. Elena Myasoedova, Genetics, genomics, Gerstner Family Career Development Awards, mayo clinic


July 18, 2019

Targeting therapy to each patient’s unique cancer

By Sharon Rosen Sharon Rosen

Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center will speak on Decision Support  for Precision […]

View full entry

Tags: #CIMCon19, #Mayo Cllinic, breast cancer, center for individualized medicine, Dr. Alan Bryce, Dr. Funda Meric-Bernstam, Genetic Sequencing, Genetic Testing, Individualizing Medicine Conference 2019, lymphoma, MD Anderson, Melanoma


July 9, 2019

Mayo experts provide insights into how genes affect medication response

By Sharon Rosen Sharon Rosen

Pharmacogenomics – how a person’s genes affect medication response – is touching virtually every area of medical care.  Findings from the Mayo Clinic RIGHT study (Right Drug, Right Dose, Right Time–Using Genomic Data to Individualize Treatment) showed that 99% of participants had at least one genetic variant that may affect their response to medications.    […]

View full entry

Tags: #addiction, #anti-seizure medication, #Center for Individualized Mediicine, #Dr. Lauren Cornell, #Dr. Sanjay Bagaria, #Dr. William Freeman, #Dr. William Palmer, #drug-gene interactions, #epilepsy, #estrogen receptor positive breast cancer, #medical education, #neurological diseases


June 28, 2019

Can BioBanks Help Close Gaps in Health Outcomes?

By Barbara J. Toman Barbara J. Toman

By definition, personalized medicine requires diversity. One-size-fits-all doesn’t work for every individual, especially members of groups that are medically underserved. In collaboration with Arizona State University and Mountain Park Health Center (MPHC) in Phoenix, Mayo Clinic’s Center for Individualized Medicine has created a biobank to enhance the diversity of Mayo’s medical research. Sangre Por Salud (Spanish for […]

View full entry

Tags: #Arizona State University, #diabetes, #disease risk, #Dr. Richard Caselli, #Giovanna Moreno Garzon, #Health Disparities, #high blood pressure, #Mayo Clinic Biobank, #Mountain Park Health Center, #obesity, #Sangre Por Salud, #underserved populations


June 3, 2019

Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment

By Sharon Rosen Sharon Rosen

Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and your family members […]

View full entry

Tags: #cancer risk, #Center for Individualized Mediicine, #gastrointestinal cancer, breast cancer, colorectal cancer, Dr. Niloy "Jewel" Samadder, Genetic Testing, genomics, hereditary cancer, lynch syndrome, mayo clinic, Mayo Clinic Proceedings


May 29, 2019

Individualizing Medicine 2019 Conference – practical precision cancer care approaches for your patients

By Sharon Rosen Sharon Rosen

Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]

View full entry

Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma


November 5, 2018

Pharmacogenomics: finding the right drug, dose for cancer therapy

By Sharon Rosen Sharon Rosen

Each year, nearly 300,000 patients receive the lifesaving chemotherapy 5-fluorouracil (5-FU) to treat many types of cancer, including colorectal, breast, bowel, skin, pancreatic, and esophageal cancer. While it can be an effective treatment, it doesn’t work for everyone. In fact, up to 30 percent of those who receive the standard dose can have serious, life-threatening […]

View full entry

Tags: #5-fluorouracil, #5-FU chemotherapy, #chemotherapy side effects, #DPYD gene, #drug-gene interactions, #gene verifier model, breast cancer, chemotherapy, colorectal cancer, mayo clinic, Mayo Clinic Cancer Center, Mayo Clinic Center for Individualized Medicine


Contact Us · Privacy Policy